FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.89B
1-Year Est. Return 201.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+201.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.89B
AUM Growth
+$163M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$83.2M
2
+$31.1M
3
+$23M
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$19.1M
5
PVLA
Palvella Therapeutics
PVLA
+$16.7M

Top Sells

1
+$70.9M
2
+$51M
3
+$33.3M
4
RVMD icon
Revolution Medicines
RVMD
+$12.3M
5
TVTX icon
Travere Therapeutics
TVTX
+$9.23M

Sector Composition

1 Healthcare 99.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXEO icon
26
Lexeo Therapeutics
LXEO
$397M
$25.4M 0.65%
4,424,725
ALKS icon
27
Alkermes
ALKS
$7.04B
$24.8M 0.64%
700,647
ACRS icon
28
Aclaris Therapeutics
ACRS
$619M
$18.5M 0.48%
+4,925,374
GLUE icon
29
Monte Rosa Therapeutics
GLUE
$1.67B
$16.4M 0.42%
+1,000,000
IMCR icon
30
Immunocore
IMCR
$1.43B
$14.6M 0.38%
484,782
+100,000
MNKD icon
31
MannKind Corp
MNKD
$1.09B
$14.5M 0.37%
5,900,000
+1,675,000
VALN
32
Valneva
VALN
$564M
$14.3M 0.37%
2,291,666
EOLS icon
33
Evolus
EOLS
$425M
$10.8M 0.28%
2,630,665
NAMSW icon
34
NewAmsterdam Pharma Warrant
NAMSW
$10M 0.26%
500,333
ALLO icon
35
Allogene Therapeutics
ALLO
$766M
$9.26M 0.24%
3,796,668
-72,082
AUTL
36
Autolus Therapeutics
AUTL
$490M
$6.14M 0.16%
4,447,910
-175,414
IBIO icon
37
iBio
IBIO
$93.9M
$3.71M 0.1%
1,953,467
XLO icon
38
Xilio Therapeutics
XLO
$56.1M
$3.55M 0.09%
422,505
-2
ABVX
39
Abivax
ABVX
$10.4B
– –
-378,300
DSGN icon
40
Design Therapeutics
DSGN
$670M
– –
-521,000
RAPT
41
DELISTED
RAPT Therapeutics
RAPT
– –
-983,333
RNAM
42
DELISTED
Avidity Biosciences
RNAM
– –
-983,125
TVTX icon
43
Travere Therapeutics
TVTX
$4.32B
– –
-241,592
1
2